Glucotrol XL
$ 14,00 – $ 170,00Price range: $ 14,00 through $ 170,00
Glycomet
$ 4,00 – $ 71,00Price range: $ 4,00 through $ 71,00
Glucovance
$ 48,00 – $ 342,00Price range: $ 48,00 through $ 342,00
Glucovance is a highly effective combination medication specifically formulated to help manage blood sugar levels in adults with type 2 diabetes. This treatment combines two powerful active ingredients, glyburide and metformin, which work synergistically to provide comprehensive glycemic control. Glyburide functions by stimulating the pancreas to release more natural insulin, while metformin reduces the amount of glucose produced by the liver and improves the body’s response to insulin. By maintaining stable glucose levels, this medication helps lower the risk of long-term health complications such as kidney damage, nerve issues, and vision problems. It serves as an essential option for individuals who require an integrated approach to diabetes management alongside a balanced diet and regular exercise.
Active substance: glibenclamide, metformin
SKU:
Glucovance
Category: Diabetes
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Glucovance belongs to a class of combination oral antidiabetic medications containing glyburide and metformin hydrochloride. It is prescribed under medical supervision as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. This combination therapy targets multiple physiological pathways involved in systemic glucose regulation.
As a prescription-only medication regulated by the US Food and Drug Administration (FDA), Glucovance must be taken strictly in accordance with individualized medical directions. Proper clinical management requires routine laboratory testing to monitor blood glucose levels, renal function, and hepatic parameters throughout treatment.
| Attribute | Details |
|---|---|
| Active ingredient | Glyburide and Metformin Hydrochloride |
| Therapeutic class | Antidiabetic combinations (Sulfonylurea and Biguanide) |
| Dosage form | Oral tablet |
| Route of administration | Oral |
| Primary purpose | Glycemic control in adults with type 2 diabetes mellitus |
| Prescription status | Prescription (Rx) only |
Clinical Profile and Drug Overview
How the drug works: Glucovance combines two antihyperglycemic agents with complementary mechanisms of action to improve glycemic control in patients with type 2 diabetes. Glyburide is a second-generation sulfonylurea that lowers blood glucose primarily by stimulating the secretion of endogenous insulin from functioning beta cells in the pancreas. Metformin hydrochloride is a biguanide that lowers both basal and postprandial plasma glucose. It acts by reducing hepatic glucose production through inhibition of gluconeogenesis, decreasing intestinal glucose absorption, and increasing peripheral glucose uptake and utilization by enhancing insulin sensitivity. Together, these complementary actions address both insulin deficiency and peripheral insulin resistance without stimulating pancreatic insulin secretion through the metformin component.
Main uses: Glucovance is indicated as an adjunct to diet and exercise to improve blood sugar management in adults diagnosed with type 2 diabetes mellitus. It is utilized when glycemic control cannot be adequately maintained with diet, exercise, or monotherapy using either a sulfonylurea or metformin alone. Glucovance is not indicated for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis, as it requires functioning pancreatic beta cells to exert its sulfonylurea activity. Prescribers evaluate patient blood glucose levels, hemoglobin A1c targets, and previous antidiabetic therapy before initiating this combination regimen.
Pharmacokinetics and Dosing Schedule
How it’s absorbed and eliminated: Following oral administration, metformin hydrochloride is absorbed primarily from the small intestine, exhibiting an absolute bioavailability of approximately 50% to 60% under fasting conditions. Metformin does not undergo hepatic metabolism and is eliminated unchanged in the urine via renal tubular secretion, with an elimination half-life of roughly 6.2 hours in individuals with normal renal function. Glyburide is rapidly absorbed from the gastrointestinal tract, reaching peak plasma concentrations within 2 to 4 hours. Glyburide is extensively bound (greater than 99%) to serum proteins, primarily albumin. It is completely metabolized in the liver to weakly active metabolites, which are excreted equally via urine and bile in feces.
Dosing schedule: Glucovance is administered orally and must be taken with meals to minimize gastrointestinal adverse effects associated with metformin and to reduce the risk of hypoglycemia associated with glyburide. The initial starting dose is determined individually based on the patient’s current treatment regimen, baseline glycemic control, and overall tolerance. Dosage titration should be gradual, based on regular blood glucose measurements, to establish the minimum effective dose required for adequate glycemic management. The total daily dosage is typically divided into two doses given with breakfast and dinner, without exceeding maximum daily recommended limits set by clinical guidelines.
If you skip a dose: If a scheduled dose of Glucovance is missed, it should be taken as soon as remembered with the next scheduled meal. However, if it is nearly time for the subsequent scheduled dose, the missed dose should be skipped entirely, and the normal dosing schedule resumed. Patients must never take a double dose or extra tablets to make up for a missed dose, as doubling the medication significantly increases the risk of severe hypoglycemia. Maintaining a consistent regular meal schedule is essential when managing skipped or delayed doses.
Safety Profile, Side Effects, and Interactions
Adverse reactions: The overall side effect profile of Glucovance reflects the combined safety profiles of its active components. Gastrointestinal symptoms are common during initial therapy, including nausea, diarrhea, abdominal pain, flatulence, vomiting, and loss of appetite; these effects often diminish with continued treatment and proper administration with food. Hypoglycemia (low blood sugar) is a notable adverse reaction primarily attributable to the glyburide component. Other reported adverse events include metallic taste, headache, dizziness, and mild dermatologic reactions such as rash or pruritus. Monitoring blood glucose helps detect hypoglycemic events early.
What to avoid while taking it: Patients taking Glucovance must avoid excessive alcohol consumption, both acute binge drinking and chronic consumption. Alcohol enhances the effect of metformin on lactate metabolism, significantly raising the risk of metformin-associated lactic acidosis, while simultaneously exerting unpredictable effects on blood glucose levels that increase the risk of severe hypoglycemia. Patients should also avoid prolonged periods of fasting, severe caloric restriction, or skipping meals, as regular carbohydrate intake is required to offset the insulin-stimulating action of glyburide.
Compatibility with other medicines: Co-administration of Glucovance with certain agents requires clinical caution and dosage adjustment. Thiazide diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, and calcium channel blockers may produce hyperglycemia and lead to loss of glycemic control. Conversely, drugs such as nonsteroidal anti-inflammatory drugs (NSAIDs), fluoroquinolones, sulfonamides, and monoamine oxidase inhibitors may potentiate hypoglycemic effects. Additionally, intravascular administration of iodinated contrast materials in radiologic studies can lead to an acute alteration of renal function; Glucovance must be temporarily withheld prior to or at the time of such procedures as directed by a healthcare professional.
Important Precautions and Emergency Care
Important precautions: Glucovance carries a serious risk warning for metformin-associated lactic acidosis, a rare but potentially life-threatening metabolic complication. Risk factors include renal impairment, advanced age, surgical procedures, hypoxic states, and hepatic dysfunction. The drug is contraindicated in patients with severe renal impairment (defined as an estimated glomerular filtration rate [eGFR] below 30 mL/min/1.73 m²) or acute/chronic metabolic acidosis. Renal function must be assessed prior to initiating treatment and monitored at least annually thereafter. Caution is also advised in patients prone to hypoglycemia, including elderly, debilitated, or malnourished individuals.
Day-to-day use: Successful management on Glucovance involves routine daily self-monitoring of blood glucose levels according to a healthcare provider’s instructions. Patients should carry a source of fast-acting glucose (such as glucose tablets or gel) at all times to manage mild hypoglycemic episodes promptly. Maintaining standard dietary habits, regular physical activity, and consistent appointment schedules for laboratory evaluations (including hemoglobin A1c and renal function tests) are critical components of daily care.
When to get emergency care: Immediate emergency medical evaluation is necessary if patients experience severe adverse reactions. Symptoms suggestive of lactic acidosis–such as severe malaise, myalgia, respiratory distress, somnolence, and abdominal discomfort–require urgent emergency evaluation. Severe hypoglycemia presenting with confusion, seizures, or loss of consciousness also warrants emergency medical assistance.
| Emergency Symptom (Red Flag) | Possible Associated Condition | Recommended Immediate Action |
|---|---|---|
| Difficulty breathing or rapid respiration | Metformin-associated lactic acidosis | Seek emergency medical care immediately |
| Severe muscle pain, weakness, or cold limbs | Lactic acidosis / Systemic toxicity | Discontinue drug and seek immediate emergency evaluation |
| Severe confusion, seizures, or loss of consciousness | Severe hypoglycemia | Administer emergency glucagon or call 911 |
| Swelling of face, lips, tongue, or throat | Severe allergic / Hypersensitivity reaction | Obtain urgent emergency medical attention |
| Severe persistent abdominal pain with vomiting | Lactic acidosis / Acute metabolic decompensation | Contact emergency medical service right away |
Frequently Asked Questions
Common Questions Regarding Glucovance
Why should Glucovance always be taken with meals?
Taking Glucovance with food serves two primary clinical functions: it reduces gastrointestinal side effects such as nausea, abdominal cramping, and diarrhea commonly caused by metformin, and it provides glucose absorption from food to reduce the risk of hypoglycemia triggered by glyburide.
What should be done if symptoms of low blood sugar occur?
If mild to moderate hypoglycemic symptoms occur (such as shakiness, sweating, dizziness, or rapid heartbeat), patients should immediately consume 15 to 20 grams of fast-acting carbohydrates, such as glucose tablets, fruit juice, or non-diet soda. Blood sugar should be rechecked after 15 minutes, and if levels remain low, the treatment should be repeated. Persistent or severe symptoms require medical evaluation.
Is it necessary to stop Glucovance before undergoing certain X-ray or CT scans?
Yes. Diagnostic procedures involving intravascular iodinated contrast agents can temporarily impair renal function, leading to metformin accumulation and an increased risk of lactic acidosis. Healthcare providers usually instruct patients to stop taking Glucovance at the time of or prior to the procedure and refrain from restarting until 48 hours after, once renal function has been re-evaluated and confirmed stable.
Can Glucovance be taken during pregnancy or while breastfeeding?
Glucovance is generally not recommended during pregnancy or lactation. Maintaining stable blood glucose control during pregnancy is vital, and insulin is typically preferred over oral sulfonylureas and biguanides. Patients who are pregnant, planning to become pregnant, or breastfeeding should consult their healthcare provider to discuss safe alternative therapies.
How does renal function impact the safe use of Glucovance?
Because metformin is eliminated primarily by the kidneys, reduced renal clearance increases drug accumulation and the risk of severe lactic acidosis. Renal function must be checked via estimated glomerular filtration rate (eGFR) prior to therapy. Glucovance is contraindicated if eGFR drops below 30 mL/min/1.73 m² and requires careful evaluation if eGFR is between 30 and 45 mL/min/1.73 m².
In accordance with FDA requirements.
This content is informational and does not replace a consultation with your doctor or pharmacist.
Additional information
| Dosage |
2.5mg+400mg ,5mg+500mg |
|---|---|
| Package |
30 pills ,60 pills ,90 pills ,120 pills ,180 pills ,270 pills ,360 pills |
| Ενεργός Ουσία | , |
Related products
Actoplus Met
$ 43,00 – $ 343,00Price range: $ 43,00 through $ 343,00
Active substance: metformin, Pioglitazone
More Details
This product has multiple variants. The options may be chosen on the product page
Diabecon
$ 57,00 – $ 345,00Price range: $ 57,00 through $ 345,00
Active substance: Diabecon
More Details
This product has multiple variants. The options may be chosen on the product page
Empagliflozin
$ 153,00 – $ 727,00Price range: $ 153,00 through $ 727,00
Active substance: Empagliflozin
More Details
This product has multiple variants. The options may be chosen on the product page
Glucophage
$ 28,00 – $ 97,00Price range: $ 28,00 through $ 97,00
Active substance: metformin
More Details
This product has multiple variants. The options may be chosen on the product page
Glucophage Trio
$ 96,00 – $ 187,00Price range: $ 96,00 through $ 187,00
More Details
This product has multiple variants. The options may be chosen on the product page
Insulin Glargine
$ 112,00 – $ 267,00Price range: $ 112,00 through $ 267,00
Active substance: Insulin Glargine
More Details
This product has multiple variants. The options may be chosen on the product page
Metformin
$ 33,00 – $ 190,00Price range: $ 33,00 through $ 190,00
Active substance: metformin
More Details
This product has multiple variants. The options may be chosen on the product page
Precose
$ 46,00 – $ 294,00Price range: $ 46,00 through $ 294,00
Active substance: Acarbose
More Details
This product has multiple variants. The options may be chosen on the product page
